dc.contributor.author |
Tokajian, Sima |
|
dc.contributor.author |
Timani, Rola |
|
dc.contributor.author |
Issa, Nahla |
|
dc.contributor.author |
Araj, George |
|
dc.date.accessioned |
2016-04-01T12:31:20Z |
|
dc.date.available |
2016-04-01T12:31:20Z |
|
dc.date.copyright |
2012 |
|
dc.date.issued |
2016-04-01 |
|
dc.identifier.issn |
2231-0886 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10725/3480 |
|
dc.description.abstract |
Aims: Typing and characterization of 100 P. aeruginosa clinical isolates by pulse field gel
electrophoresis (PFGE) to detect changes in the clonal composition of local strains and to
correlate banding patterns with site of infection, drug resistance and Type III secretion
system effectors.
Methodology: A total of 100 P. aeruginosa isolates obtained from clinical specimens were
used to study resistance profiles, PFGE banding patterns and virulence determinants.
Results: Results from antimicrobial susceptibility testing yielded showed that 77 of the
strains were multi drug resistant (MDR). Grouping isolates as non-susceptible when tested
intermediate and resistant accordingly showed that resistance was 25% each for imipenem
and piperacillin-tazobactam, while it was 29% for ceftazidime these drugs are among the
ones most commonly used in treating infections caused by P. aeruginosa. Studying
effectors released by the type III secretion system including exoU and exoS revealed that
48% of the isolates harbored exoS toxin gene and 46% the exoU, with 3% having both and
8% having none. When the different pulsotypes were compared on a dendogram, 45
Short Communication
British Microbiology Research Journal, 2(4): 243-250, 2012
244
groups emerged showing vast differences among the isolates. Conclusion: This study showed the emergence of drug resistance in P. aeruginosa against
the antimicrobial agents being routinely used for treatment and revealed the likely presence
of co-selected traits that result in highly virulent and resistant strains. Further clinical
investigations are warranted to combat infections caused by this important human pathogen in Lebanon. |
en_US |
dc.language.iso |
en |
en_US |
dc.title |
Molecular Characterization, Multiple Drug Resistance, and Virulence Determinants of Pseudomonas aeruginosa Isolated from Lebanon |
en_US |
dc.type |
Article |
en_US |
dc.description.version |
Published |
en_US |
dc.author.school |
SAS |
en_US |
dc.author.idnumber |
199736770 |
en_US |
dc.author.woa |
N/A |
en_US |
dc.author.department |
Natural Sciences |
en_US |
dc.description.embargo |
N/A |
en_US |
dc.relation.journal |
British Microbiology Research |
en_US |
dc.journal.volume |
2 |
en_US |
dc.journal.issue |
4 |
en_US |
dc.article.pages |
243-250 |
en_US |
dc.keywords |
Keywords: P. aeruginosa |
en_US |
dc.keywords |
Typing |
en_US |
dc.keywords |
Toxins |
en_US |
dc.keywords |
PFGE |
en_US |
dc.keywords |
Antibiotic resistance |
en_US |
dc.identifier.ctation |
Tokajian, S., Timani, R., Issa, N., & Araj, G. (2012). Molecular characterization, multiple drug resistance, and virulence determinants of Pseudomonas aeruginosa isolated from Lebanon. British Microbiology Research Journal, 2(4), 243. |
en_US |
dc.author.email |
stokjian@lau.edu.lb |
|
dc.identifier.url |
http://search.proquest.com/openview/7b472cea7f39308cb6d5f7a4e6bebd00/1?pq-origsite=gscholar |
|
dc.orcid.id |
https://orcid.org/0000-0002-3653-8940 |
|